206 related articles for article (PubMed ID: 29667444)
1. AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells.
Rafael D; Gener P; Andrade F; Seras-Franzoso J; Montero S; Fernández Y; Hidalgo M; Arango D; Sayós J; Florindo HF; Abasolo I; Schwartz S; Videira M
Drug Deliv; 2018 Nov; 25(1):961-972. PubMed ID: 29667444
[TBL] [Abstract][Full Text] [Related]
2. Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells.
Parmar MB; Meenakshi Sundaram DN; K C RB; Maranchuk R; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
Acta Biomater; 2018 Jan; 66():294-309. PubMed ID: 29183848
[TBL] [Abstract][Full Text] [Related]
3. Multiple siRNA delivery against cell cycle and anti-apoptosis proteins using lipid-substituted polyethylenimine in triple-negative breast cancer and nonmalignant cells.
Parmar MB; Arteaga Ballesteros BE; Fu T; K C RB; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
J Biomed Mater Res A; 2016 Dec; 104(12):3031-3044. PubMed ID: 27465922
[TBL] [Abstract][Full Text] [Related]
4. Redox-responsive polymeric micelles formed by conjugating gambogic acid with bioreducible poly(amido amine)s for the co-delivery of docetaxel and MMP-9 shRNA.
Kang Y; Lu L; Lan J; Ding Y; Yang J; Zhang Y; Zhao Y; Zhang T; Ho RJY
Acta Biomater; 2018 Mar; 68():137-153. PubMed ID: 29288085
[TBL] [Abstract][Full Text] [Related]
5. Biocompatible cationic pullulan-g-desoxycholic acid-g-PEI micelles used to co-deliver drug and gene for cancer therapy.
Chen L; Ji F; Bao Y; Xia J; Guo L; Wang J; Li Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):418-429. PubMed ID: 27770912
[TBL] [Abstract][Full Text] [Related]
6. Single-walled carbon nanotubes functionalized with aptamer and piperazine-polyethylenimine derivative for targeted siRNA delivery into breast cancer cells.
Mohammadi M; Salmasi Z; Hashemi M; Mosaffa F; Abnous K; Ramezani M
Int J Pharm; 2015 May; 485(1-2):50-60. PubMed ID: 25712164
[TBL] [Abstract][Full Text] [Related]
7. Pluronic F127 micelles improve the stability and enhance the anticancer stem cell efficacy of citral in breast cancer.
Abu-Serie MM; Andrade F; Cámara-Sánchez P; Seras-Franzoso J; Rafael D; Díaz-Riascos ZV; Gener P; Abasolo I; Schwartz S
Nanomedicine (Lond); 2021 Jul; 16(17):1471-1485. PubMed ID: 34160295
[No Abstract] [Full Text] [Related]
8. Effective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapy.
Falamarzian A; Aliabadi HM; Molavi O; Seubert JM; Lai R; Uludağ H; Lavasanifar A
J Biomed Mater Res A; 2014 Sep; 102(9):3216-28. PubMed ID: 24167124
[TBL] [Abstract][Full Text] [Related]
9. Polymeric Micellar Formulation Enhances Antimicrobial and Anticancer Properties of Salinomycin.
Sousa C; Gouveia LF; Kreutzer B; Silva-Lima B; Maphasa RE; Dube A; Videira M
Pharm Res; 2019 Apr; 36(6):83. PubMed ID: 30989413
[TBL] [Abstract][Full Text] [Related]
10. Intracellular Delivery of Anti-SMC2 Antibodies against Cancer Stem Cells.
Montero S; Seras-Franzoso J; Andrade F; Martinez-Trucharte F; Vilar-Hernández M; Quesada M; Xandri H; Arango D; Abasolo I; Rafael D; Schwartz S
Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32098204
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
Glackin CA
Enzymes; 2018; 44():83-101. PubMed ID: 30360816
[TBL] [Abstract][Full Text] [Related]
12. Redox-Activatable ATP-Depleting Micelles with Dual Modulation Characteristics for Multidrug-Resistant Cancer Therapy.
Wang H; Li Y; Zhang M; Wu D; Shen Y; Tang G; Ping Y
Adv Healthc Mater; 2017 Apr; 6(8):. PubMed ID: 28152267
[TBL] [Abstract][Full Text] [Related]
13. Liposomal co-delivery-based quantitative evaluation of chemosensitivity enhancement in breast cancer stem cells by knockdown of GRP78/CLU.
Samson AAS; Park S; Kim SY; Min DH; Jeon NL; Song JM
J Liposome Res; 2019 Mar; 29(1):44-52. PubMed ID: 29262741
[TBL] [Abstract][Full Text] [Related]
14. Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy.
Zheng C; Zheng M; Gong P; Deng J; Yi H; Zhang P; Zhang Y; Liu P; Ma Y; Cai L
Biomaterials; 2013 Apr; 34(13):3431-8. PubMed ID: 23375952
[TBL] [Abstract][Full Text] [Related]
15. Amphiphilic poly(α)glutamate polymeric micelles for systemic administration of siRNA to tumors.
Krivitsky A; Polyak D; Scomparin A; Eliyahu S; Ofek P; Tiram G; Kalinski H; Avkin-Nachum S; Feiner Gracia N; Albertazzi L; Satchi-Fainaro R
Nanomedicine; 2018 Feb; 14(2):303-315. PubMed ID: 29127036
[TBL] [Abstract][Full Text] [Related]
16. A strategy using mesoporous polymer nanospheres as nanocarriers of Bcl-2 siRNA towards breast cancer therapy.
Wu X; Zheng Y; Yang D; Chen T; Feng B; Weng J; Wang J; Zhang K; Zhang X
J Mater Chem B; 2019 Jan; 7(3):477-487. PubMed ID: 32254735
[TBL] [Abstract][Full Text] [Related]
17. Enhanced oral bioavailability of paclitaxel in pluronic/LHR mixed polymeric micelles: preparation, in vitro and in vivo evaluation.
Dahmani FZ; Yang H; Zhou J; Yao J; Zhang T; Zhang Q
Eur J Pharm Sci; 2012 Aug; 47(1):179-89. PubMed ID: 22683386
[TBL] [Abstract][Full Text] [Related]
18. Additive Polyplexes to Undertake siRNA Therapy against CDC20 and Survivin in Breast Cancer Cells.
Parmar MB; K C RB; Löbenberg R; Uludağ H
Biomacromolecules; 2018 Nov; 19(11):4193-4206. PubMed ID: 30222931
[TBL] [Abstract][Full Text] [Related]
19. Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells.
Gener P; Gouveia LP; Sabat GR; de Sousa Rafael DF; Fort NB; Arranja A; Fernández Y; Prieto RM; Ortega JS; Arango D; Abasolo I; Videira M; Schwartz S
Nanomedicine; 2015 Nov; 11(8):1883-92. PubMed ID: 26238079
[TBL] [Abstract][Full Text] [Related]
20. Chitosan-graft-polyethylenimine for Akt1 siRNA delivery to lung cancer cells.
Jere D; Jiang HL; Kim YK; Arote R; Choi YJ; Yun CH; Cho MH; Cho CS
Int J Pharm; 2009 Aug; 378(1-2):194-200. PubMed ID: 19501140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
